FPS FACULTY

Houjun Xia

Houjun Xia

Assistant Professor

Ph.D

Email:hj.xia@siat.ac.cn

Dr. Xia is an Assistant Professor of Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS). He graduated from Wuhan University in 2004 and earned his PhD at the Kunming Institute of Zoology at the CAS in 2010. He joined the laboratory of tumor biology in Kunming Institute of Zoology at the CAS and had worked on the establishment of breast cancer animal models for 4 years. Dr. Xia pursued his postdoctoral fellowship training in University of Michigan at Ann Arbor from 2014 to 2021. Dr. Xia’s research interest has focused on T cell and macrophage biology in the context of tumor immunity and immunotherapy, especially the modulation of their autophagy on the anti-tumor immune response. 

As a postdoctoral researcher, he has carried out 2 large research projects. In project #1, he has explored how tumor metabolism affects naïve T cell phenotype and tumor immunity. In project #2, he has focused on a role of oxidative metabolism in macrophage subsets in the context of ovarian cancer. During the research period, he has published nearly 30 papers and 3 review articles in prestigious journals, including Nature Reviews Cancer, Nature, Science Immunology, Cancer Cell, Cell Metabolism, Nature Communication, JCI, CMI, and other 8 peer-review journals. He also filed 1 patent.

Research areas

Autophagy is a regulated mechanism that removes unnecessary or dysfunctional cellular components and recycles metabolic substrates. In response to stress signals in the tumor microenvironment, the autophagy pathway is altered in tumor cells and immune cells, thereby differentially affecting tumor progression, immunity, and therapy. To further understand the effect of autophagy on the cancer progression and therapy, the laboratory employs a wide range of experimental techniques including traditional biochemical and molecular biological analyses; genetic approaches including conventional and conditional gene targeting and transgenesis in mice; large scale gene expression analyses and bioinformatics. In addition, the laboratory plans to screen autophagy specific inhibitors to synergize other anti-tumor immunotherapies.